Angus M. Sinclair
IGM Biosciences (United States)(US)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease(2003)582 cited
- → Glycoengineering: The effect of glycosylation on the properties of therapeutic proteins(2005)461 cited
- → Anti-Epo receptor antibodies do not predict Epo receptor expression(2005)299 cited
- → Connection Between B Lymphocyte and Osteoclast Differentiation Pathways(2001)239 cited
- → Structure, Function, and Therapeutic Use of IgM Antibodies(2020)238 cited
- → Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML(2013)171 cited
- → Mutation of hepatocyte nuclear factor–1β inhibits Pkhd1 gene expression and produces renal cysts in mice(2004)155 cited
- → An SCL 3’ enhancer targets developing endothelium together with embryonic and adult haematopoietic progenitors(1999)137 cited
- → Functional erythropoietin receptor is undetectable in endothelial, cardiac, neuronal, and renal cells(2010)137 cited